Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide vs Furosemide + Albumin in Cirrhosis
NCT04216784Phase 4Terminated
- Sponsor
- Rush University Medical Center
- Start
- Dec 2019
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in Fluid overload, sponsored by Rush University Medical Center. Started Dec 2019; status: terminated.
02
Drugs
albumin (human)
03
Conditions
Fluid overload
Beyond the preview
Go deeper on NCT04216784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04216784.